Type 2 & other diabetes

Association of non‐high‐density lipoprotein cholesterol/high‐density lipoprotein cholesterol ratio with cardiovascular outcomes in patients with type 2 diabetes mellitus: Evidence from the ACCORD cohort

Diabetes Obes MetabPublished Cohort study

Main finding · MACEResult — go to the resultHazard ratio 1.12 95% CI 1.07–1.16

Authors' conclusion

NHHR is a predictor of the risk of developing MACEs and overall mortality in patients with T2DM, with higher NHHR values independently associated with increased future MACE risks after full adjustment for confounders.

Study context

Population
Patients with T2D in the ACCORD cohort
Participants
10,188 patients
Exposure
Per 1-unit increase in non-HDL-C/HDL-C ratio
Outcome
MACE and overall mortality
Methodological detailssecondary analysis of the ACCORD cohort
  • Secondary analysis of the ACCORD cohort

Main finding

MACE

Hazard ratio

1.12

95% CI 1.07–1.16

P < 0.0001

Per 1-unit increase in NHHR
HR 1.12 (95% CI 1.07–1.16); P < 0.0001

Per 1-unit increase in NHHR, as printed

As reported in the abstract

Observational data: associations, not effects.

Further findings

OutcomeHR (95% CI)P value
Overall mortalityAdjusted1.05 (1.01–1.10)P = 0.0256
CVD mortalityAdjusted1.10 (1.03–1.18)P = 0.0074
Non-fatal MIAdjusted1.12 (1.05–1.18)P = 0.0002
Non-fatal strokeAdjusted1.11 (1.02–1.20)P = 0.0123

Non-linearity and threshold of NHHR for MACE

Threshold for MACE (two-stage linear regression)
6.28
Non-linear relationship between NHHR and MACE (non-linearity p < 0.001)
Adding NHHR to conventional model significantly enhanced predictive accuracy for MACE

Original publication

Association of non‐high‐density lipoprotein cholesterol/high‐density lipoprotein cholesterol ratio with cardiovascular outcomes in patients with type 2 diabetes mellitus: Evidence from the ACCORD cohort. Diabetes Obes Metab. Published 16 October 2024. doi:10.1111/dom.16018

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.